CAMPATH1H therapy for patients with refractory chronic lymphocytic leukaemia (CLL).

被引：0
|
作者：
Rawstron, AC
Davies, FE
Evans, P
Morgan, GJ
Jamil, A
Galvin, MC
Haynes, AP
Hale, G
Hillmen, P
机构：
[1] UNIV LEEDS,GEN INFIRM,DEPT HAEMATOL,LEEDS LS1 3EX,W YORKSHIRE,ENGLAND
[2] PINDERFIELDS GEN HOSP,WAKEFIELD,ENGLAND
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2356 / 2356
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY (RR) CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) IN ENGLAND
    Hassan, F.
    Peng, S.
    Dorman, E.
    Sorensen, S.
    Thompson, G.
    Lee, J.
    VALUE IN HEALTH, 2017, 20 (09) : A441 - A441
  • [22] Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia
    Kennedy, B
    Rawstron, A
    Carter, C
    Ryan, M
    Speed, K
    Lucas, G
    Hillmen, P
    BLOOD, 2002, 99 (06) : 2245 - 2247
  • [23] CAMPATH(R)1-H (CAMP) THERAPY CAUSES CLEARING OF LYMPHOCYTIC INFILTRATION (LY-INF) OF BONE-MARROW (BM) IN ADVANCED, REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    JANSON, D
    HOFFMAN, M
    FUCHS, A
    SHEVDE, N
    NISSELHOROWITZ, S
    SATTLER, M
    DESAI, S
    WORMSLEY, SB
    RAI, KR
    BLOOD, 1994, 84 (10) : A526 - A526
  • [24] Phase I study of rituximab and CAMPATH-1H in patients with relapsed or refractory chronic lymphocytic leukemia.
    Nabhan, C
    Tallman, MS
    Riley, MB
    Fitzpatrick, J
    Gordon, LI
    Gartenhaus, R
    Kuzel, T
    Siegel, R
    Rosen, ST
    BLOOD, 2001, 98 (11) : 365A - 365A
  • [25] Venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia
    Yang, Lin
    Banerji, Versha
    LANCET ONCOLOGY, 2024, 25 (04): : 413 - 414
  • [26] The monoclonal antibodies Campath-1H and rituximab in the therapy of chronic lymphocytic leukemia
    Schulz, H
    Winkler, U
    Staak, JO
    Engert, A
    ONKOLOGIE, 2000, 23 (06): : 526 - 532
  • [27] Is there an epidemic of chronic lymphocytic leukaemia (CLL) in China?
    Yang, Shenmiao
    Gale, Robert Peter
    Huang, Xiaojun
    LEUKEMIA & LYMPHOMA, 2017, 58 : 237 - 238
  • [28] Diagnostic issues in chronic lymphocytic leukaemia (CLL)
    Matutes, Estella
    Attygalle, Ayoma
    Wotherspoon, Andrew
    Catovsky, Daniel
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2010, 23 (01) : 3 - 20
  • [29] Affinity maturation in chronic lymphocytic leukaemia (CLL).
    Lane, BS
    Lin, K
    Pettitt, AR
    Sherrington, PD
    BLOOD, 2003, 102 (11) : 429A - 429A
  • [30] RESISTANCE TO VENETOCLAX IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)
    Thijssen, Rachel
    Anderson, Mary Ann
    Teh, Charis
    Trussart, Marie
    Blombery, Piers
    Birkinshaw, Richard
    Gong, Jianan
    Gray, Daniel
    Huang, David
    Roberts, Andrew
    EXPERIMENTAL HEMATOLOGY, 2019, 76 : S88 - S88
12345